BCS Stock Analysis: Barclays | NYSE
Banks - Diversified | NYSE, USA | Market Cap: 90.091m USD | 12M Return: 51.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 129M
EPS Trend: 74.8%
Qual. Beats: 0
Rev. Trend: 89.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: under 40 is mostly noise, over 50 gets interesting, and over 70 is strong.
Barclays PLC (NYSE: BCS) is a London-headquartered global financial services company founded in 1690, making it one of the oldest banking institutions in the UK. It operates through five main segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank and Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank. The company offers a broad range of services including retail banking (current accounts, savings, mortgages, credit cards, and loans), wholesale and investment banking, wealth and investment management, and securities dealing. As a diversified bank, Barclays generates revenue across both consumer-facing and corporate/institutional lines, and trades on the NYSE as an American Depositary Receipt (ADR), allowing US investors to hold shares in the UK-domiciled company.
- UK net interest margins compress as BoE cuts rates
- Investment Banking revenue rises on FICC and advisory recovery
- US credit card losses climb as borrower delinquencies worsen
| Net Income: 7.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -0.82 > 1.0 |
| NWC/Revenue: -858.0% < 20% (prev -780.1%; Δ -77.85% < -1%) |
| CFO/TA -0.00 > 3% & CFO -6.21b > Net Income 7.23b |
| Net Debt (-290b) to EBITDA (11.0b): -26.41 < 3 |
| Current Ratio: 0.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.43b) vs 12m ago -4.11% < -2% |
| Gross Margin: 91.39% > 18% (prev 92.22%; Δ -0.83% > 0.5%) |
| Asset Turnover: 1.74% > 50% (prev 1.69%; Δ 0.04% > 0%) |
| Interest Coverage Ratio: 0.42 > 6 (EBIT TTM 9.21b / Interest Expense TTM 21.7b) |
| A: -0.14 (Total Current Assets 427b - Total Current Liabilities 672b) / Total Assets 1695b |
| B: 0.03 (Retained Earnings 58.8b / Total Assets 1695b) |
| C: 0.01 (EBIT TTM 9.21b / Avg Total Assets 1644b) |
| D: 0.05 (Book Value of Equity 76.7b / Total Liabilities 1618b) |
| Altman-Z'' = -0.75 = B |
As of July 02, 2026, the stock is trading at USD 26.86 with a total of 4,310,654 shares traded. Over the past week, the price has changed by +2.52%, over one month by +11.22%, over three months by +24.92% and over the past year by +51.79%.
Current recommended Stop Loss: 25.80 (which is 3.9% or 1.6 ATR below the current price).
Barclays has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 29.1 | 8.2% |
Market Cap GBP = 68.0b (90.1b USD * 0.7547 USD.GBP)
P/E Trailing = 11.7193
P/E Forward = 9.8328
P/S = 3.3254
P/B = 0.8926
P/EG = 1.639
Revenue TTM = 28.6b GBP
EBIT TTM = 9.21b GBP
EBITDA TTM = 11.0b GBP
Long Term Debt = 76.7b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 73.1b GBP (from shortTermDebt, last fiscal year)
Debt = 137b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -290b GBP (calculated: Debt 137b - CCE 426b)
Enterprise Value = 68.0b GBP (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.42 (Ebit TTM 9.21b / Interest Expense TTM 21.7b)
EV/FCF = -8.43x (Enterprise Value 68.0b / FCF TTM -8.07b)
FCF Yield = -11.87% (FCF TTM -8.07b / Enterprise Value 68.0b)
FCF Margin = -28.26% (FCF TTM -8.07b / Revenue TTM 28.6b)
Net Margin = 25.33% (Net Income TTM 7.23b / Revenue TTM 28.6b)
Gross Margin = 91.39% ((Revenue TTM 28.6b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 89.68% (prev 92.30%)
Tobins Q-Ratio = 0.04 (Enterprise Value 68.0b / Total Assets 1695b)
Interest Expense / Debt = 15.85% (Interest Expense 21.7b / Debt 137b)
Taxrate = 21.04% (1.94b / 9.21b)
NOPAT = 7.27b (EBIT 9.21b * (1 - 21.04%))
Current Ratio = 0.64 (Total Current Assets 427b / Total Current Liabilities 672b)
Debt / Equity = 1.78 (Debt 137b / totalStockholderEquity, last quarter 76.7b)
Debt / EBITDA = -26.41 (Net Debt -290b / EBITDA 11.0b)
Debt / FCF = 35.88 (negative FCF - burning cash) (Net Debt -290b / FCF TTM -8.07b)
Total Stockholder Equity = 76.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.44% (Net Income 7.23b / Total Assets 1695b)
RoE = 9.43% (Net Income TTM 7.23b / Total Stockholder Equity 76.7b)
RoCE = 6.00% (EBIT 9.21b / Capital Employed (Equity 76.7b + L.T.Debt 76.7b))
RoIC = 0.66% (NOPAT 7.27b / Invested Capital 1095b)
WACC = 11.66% (E(68.0b)/V(205b) * Re(9.94%) + D(137b)/V(205b) * Rd(15.85%) * (1-Tc(0.21)))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.67 | Cagr: -48.23%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 74.78 | EPS CAGR: 11.95% | SUE: 0.41 | # QB: 0
Revenue Correlation: 88.96 | Revenue CAGR: 5.05% | SUE: 0.00 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.74 | Chg30d=+2.26% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=2.83 | Chg30d=-0.98% | Revisions=+0% | GrowthEPS=+21.6% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=3.40 | Chg30d=-0.08% | Revisions=+33% | GrowthEPS=+20.2% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +33%